Our Platform
Intelligence Layer
We built a computational framework that enables each step of personalized medicine, from multi-modal data integration to biomarker development to forecasting cancer outcomes, delivered as actionable clinical reports that guide therapy decisions.
Tumor evolution
Treatment response
Resistance mechanism
What Our Intelligence Layer Enables
Multi-Modal Data Integration
ctDNA (mutation + methylation), tumor imaging, EHR, and optional tumor DNA/RNA. Non-invasive blood and clinical sampling with optional tissue.
Dynamic Forecasting
Forecasts tumor size, evolution and drug response during multiple lines of treatment for any cancer type. Identifies resistance mechanisms emerging within tumor.
Biomarker Offerings
Endorse bx
Uses RNA/DNA-seq from tumor biopsy to stratify patients by endocrine therapy response at any disease stage. Methods of treating breast cancer (Patent PCT/US21/55285).
- • 5 retrospective cohorts
- • 2 prospective clinical trials
- • Fully interpretable, clinic-ready
- • Automated biopsy-to-report pipeline